DoW Breast Cancer, Clinical Research Extension Award
This grant funds projects that extend data collection and analysis in breast cancer clinical studies to improve patient outcomes, requiring involvement of breast cancer consumer advocates.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 24, 2026: Pre-Application (Letter of Intent) | July 8, 2026: Full Application | July 13, 2026: End of Application Verification Period
Funding Amounts: Estimated total program funding: $15.4M; up to $7M (single PI) or $8.4M (Partnering PI Option) over max 4 years; ~2 awards anticipated.
Summary: Funds research to extend data collection, follow-up, and analysis of breast cancer clinical studies to maximize patient impact and address knowledge gaps.
Key Information: Requires two or more breast cancer consumer advocates on the research team.
Description
This opportunity, offered by the Dept. of the Army's USAMRAA through the Breast Cancer Research Program (BCRP), supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The goal is to increase the clinically relevant impact of patient participation by addressing knowledge lost due to early trial termination, limited follow-up, or suboptimal data/sample collection. Projects must address at least one of the BCRP’s FY26 overarching challenges or provide strong justification for exception.
Distinctive features include mandatory inclusion of at least two breast cancer consumer advocates on the research team, and the option to apply as a single Principal Investigator (PI) or as two partnering PIs (Initiating and Partnering PI). Projects cannot propose to initiate a new clinical trial or enroll new patients in ongoing trials; rather, they should focus on extending and leveraging existing or completed studies.
